Compounds > fusidic acid
Page last updated: 2024-09-04

fusidic acid and benzbromarone

fusidic acid has been researched along with benzbromarone in 5 studies

Compound Research Comparison

Studies
(fusidic acid)		Trials
(fusidic acid)		Recent Studies (post-2010)
(fusidic acid)		Studies
(benzbromarone)		Trials
(benzbromarone)		Recent Studies (post-2010) (benzbromarone)
1,74211734448259208

Protein Interaction Comparison

ProteinTaxonomyfusidic acid (IC50)benzbromarone (IC50)
envelope glycoproteinHuman immunodeficiency virus 112.8
nuclear receptor corepressor 2 isoform 2Homo sapiens (human)4.811
peroxisome proliferator-activated receptor gamma isoform 2Homo sapiens (human)4.811
Adenosine receptor A3Homo sapiens (human)5.222
60 kDa heat shock protein, mitochondrialHomo sapiens (human)9.1
Cytochrome P450 2C9 Homo sapiens (human)1.0895
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)5.222
Mitogen-activated protein kinase 1Homo sapiens (human)1.946
Multidrug resistance-associated protein 1 Homo sapiens (human)4
5-hydroxytryptamine receptor 2BHomo sapiens (human)1.804
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)5.222
Cytochrome P450 2J2Homo sapiens (human)4.26
10 kDa heat shock protein, mitochondrialHomo sapiens (human)9.1
Aldo-keto reductase family 1 member C1Homo sapiens (human)0.048
Mitogen-activated protein kinase 14Homo sapiens (human)1.235
Solute carrier family 22 member 6Homo sapiens (human)4.6
Monocarboxylate transporter 2Rattus norvegicus (Norway rat)9
Solute carrier family 22 member 12Homo sapiens (human)0.8695
Eyes absent homolog 3Homo sapiens (human)8.3
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.2
M17 leucyl aminopeptidasePlasmodium falciparum 3D781.89
M1-family alanyl aminopeptidasePlasmodium falciparum 3D762.78

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1

Reviews

1 review(s) available for fusidic acid and benzbromarone

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

4 other study(ies) available for fusidic acid and benzbromarone

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013